Retrospective Cohort Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. May 14, 2015; 21(18): 5505-5512
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5505
Table 1 Characteristics of the patients n (%)
LRR (n = 152)ORR (n = 254)P value
Age1 (yr)59 (24-90)55 (19-86)0.033
Sex0.600
Male95 (62.5)151 (59.4)
Female57 (37.5)103 (40.6)
BMI (kg/m2)22.7 (11.1)23.1 (9.5)0.369
ASA0.542
13650
298177
31827
Tumor location0.837
Upper rectum (10.1-15.0 cm)39 (25.7)59 (23.2)
Middle (5.1-10.0 cm)60 (39.5)101 (39.8)
Lower rectum (0-5 cm)53 (34.9)94 (37.0)
Tumor stage0.259
II78 (51.3)115 (45.3)
III74 (48.7)139 (54.7)
Cell differentiation0.192
Low15 (9.9)41 (16.1)
Middle101 (66.4)161 (63.4)
High36 (23.7)52 (20.5)
Neoadjuvant chemoradiotherapy13 (8.6)16 (6.3)0.429
Postoperative chemotherapy0.745
Total cycle30 (19.7)51 (20.1)
Partial cycle18 (11.8)24 (9.4)
Abdominal surgery history21 (13.8)28 (11.0)0.433
Follow-up1 (mo)63 (28-112)65 (32-118)0.211